Vivani Medical, Inc.(VANI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $8.9M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
VANI Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Vivani Medical, Inc. (VANI), a Healthcare sector company. VANI is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $8.9m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Vivani Medical, Inc. reports net income of $-6.4M, free cash flow of $-6.1M. Top institutional holders of VANI by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Tanager Wealth Management LLP, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. VANI trades on the Nasdaq exchange and files with the SEC under CIK 1266806. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VANI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Vivani Medical, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-6.4M
Free Cash Flow
Q2 2026
$-6.1M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
Net Income
-13.3% YoYOperating Income
-11.7% YoYEPS (Diluted)
+0.0% YoYTotal Assets
-5.2% YoYTotal Debt
Op. Cash Flow
-17.0% YoYFree Cash Flow
-19.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — | — | — |
| Net Income | $-26.6M -13.3% | $-23.5M +8.4% | $-25.7M -84.7% | $-13.9M -8.7% | $-12.8M +14.2% | $-14.9M |
| Operating Income | $-27.6M -11.7% | $-24.7M +8.5% | $-27.0M -26.9% | $-21.2M -59.4% | $-13.3M +10.6% | $-14.9M |
| EPS (Diluted) | $-0.43 +0.0% | $-0.43 +14.0% | $-0.50 | — | — | — |
| Total Assets | $39.4M -5.2% | $41.6M -9.2% | $45.8M -10.4% | $51.1M +837.6% | $5.5M +22.3% | $4.5M |
| Total Debt | — | — | — | — | — | $2.2M |
| Operating Cash Flow | $-24.3M -17.0% | $-20.8M +12.3% | $-23.7M -26.1% | $-18.8M -71.6% | $-11.0M +34.9% | $-16.8M |
| Free Cash Flow | $-25.5M -19.4% | $-21.3M +13.2% | $-24.6M -28.6% | $-19.1M -66.0% | $-11.5M +32.8% | $-17.2M |
Get alerted when VANI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Vivani Medical, Inc. including:
Top Institutional Holders of VANI
VANGUARD CAPITAL MANAGEMENT LLC
$2.2M1,768,077 shTanager Wealth Management LLP
$753.0K607,276 shGEODE CAPITAL MANAGEMENT, LLC
$728.9K587,745 shTUDOR INVESTMENT CORP ET AL
$509.5K410,902 shCOMMONWEALTH EQUITY SERVICES, LLC
$409.9K330,565 shVANGUARD FIDUCIARY TRUST CO
$403.6K325,462 shBlackRock, Inc.
$374.3K301,828 shMONETARY MANAGEMENT GROUP INC
$240.5K193,977 shSTATE STREET CORP
$192.2K154,965 shNORTHERN TRUST CORP
$145.0K116,907 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.2M | 1,768,077 |
| Tanager Wealth Management LLP | $753.0K | 607,276 |
| GEODE CAPITAL MANAGEMENT, LLC | $728.9K | 587,745 |
| TUDOR INVESTMENT CORP ET AL | $509.5K | 410,902 |
| COMMONWEALTH EQUITY SERVICES, LLC | $409.9K | 330,565 |
| VANGUARD FIDUCIARY TRUST CO | $403.6K | 325,462 |
| BlackRock, Inc. | $374.3K | 301,828 |
| MONETARY MANAGEMENT GROUP INC | $240.5K | 193,977 |
| STATE STREET CORP | $192.2K | 154,965 |
| NORTHERN TRUST CORP | $145.0K | 116,907 |
More Healthcare Companies
View all Healthcare →Put VANI on your watchlist
Track score changes the day Vivani Medical, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is VANI a good stock to buy?
13F Pro's AI-powered analysis of Vivani Medical, Inc. (VANI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for VANI are available on the VANI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. VANI is classified as a small company.
Which hedge funds own VANI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling VANI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Vivani Medical, Inc.'s investment landscape.